Adrian P Rowley

Title: The Innovative Contributions of Adrian P Rowley

Introduction

Adrian P Rowley is a notable inventor based in Los Angeles, California. He has made significant contributions to the field of biomedical engineering, particularly in the development of biocompatible implants. His work focuses on creating solutions that enhance the quality of life for individuals suffering from vision impairments.

Latest Patents

Rowley's most recent patent is titled "Biocompatible implants and methods of making and attaching the same." This invention provides a biocompatible silicone implant that can be securely affixed to living tissue through interaction with integral membrane proteins known as integrins. The silicone article features a laser-activated surface, which is utilized to create the implant. One application of this technology is an implantable prosthesis designed to treat blindness caused by outer retinal degenerative diseases. The device effectively bypasses damaged photoreceptors and electrically stimulates the undamaged neurons of the retina. Electrical stimulation is achieved using a silicone microelectrode array (MEA). Additionally, a safe, protein adhesive is employed to attach the MEA to the retinal surface, helping to alleviate focal pressure effects. Methods for making and attaching such implants are also included in his patent.

Career Highlights

Adrian P Rowley is affiliated with the Doheny Eye Institute, where he continues to advance his research and development efforts. His work has garnered attention for its potential to revolutionize treatments for retinal diseases and improve patient outcomes.

Collaborations

Rowley has collaborated with esteemed colleagues such as Lucien D Laude and Mark Salman Humayun. These partnerships have contributed to the innovative advancements in the field of eye care and biomedical engineering.

Conclusion

Adrian P Rowley's contributions to the field of biocompatible implants demonstrate his commitment to improving medical technology and patient care. His innovative work continues to pave the way for future advancements in treating vision impairments.